← Leaderboards
Piotr Sicinski
Dana-Farber Cancer Inst
$42,703,610
Attributed
$42,703,610
Total exposure
21
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,703,610 · 21
By mechanism
R01$31,291,961 · 11
P01$7,884,632 · 6
U19$1,370,944 · 1
P50$1,296,824 · 1
R35$855,249 · 1
R13$4,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Peter S Hammerman$2,524,867
Others in their field
Top investigators on “Cyclins”
- J. Alan Diehl · University Of Nebraska Medical Center$21,437,568
- Richard G Pestell · Yeshiva University$16,269,311
- Steven I Reed · Scripps Research Institute$16,177,190
- Bruce E Clurman · Fred Hutchinson Cancer Research Center$15,606,607
- David Owen Morgan · University Of California San Francisco$15,595,703
- David Heimbrook · Leidos Biomedical Research, Inc.$14,454,063
Research focus
CyclinsCell CycleProteinsPlayMolecularCell ProliferationMalignant NeoplasmsIn VivoCellsCyclin D1TumorPhosphotransferasesIn VitroTumorigenesisCyclin-Dependent KinasesCancer CellOncogenicAnimalsComplexOverexpressionCell TypeAblationAcuteLaboratories
Grant awards (120)
New approaches to targeting cell cycle proteins for cancer treatment$855,249
R35 · FY2025 · CA · contact PI
Cyclin C-CDK8/19 kinases in development and in cancer$525,969
R01 · FY2025 · CA · contact PI
Cyclin C-CDK8/19 kinases in development and in cancer$499,671
R01 · FY2024 · CA · contact PI
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment$442,874
R01 · FY2024 · CA · contact PI
Targeting CDK4 and CDK6 kinases in breast cancer development$345,237
P01 · FY2024 · CA · contact PI
Cyclin C-CDK8/19 kinases in development and in cancer$515,451
R01 · FY2023 · CA · contact PI
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment$468,091
R01 · FY2023 · CA · contact PI
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment$456,860
R01 · FY2023 · CA · contact PI
The Function of CDK5 in Metastasis$432,500
R01 · FY2023 · CA · contact PI
Targeting CDK4 and CDK6 kinases in breast cancer development$344,841
P01 · FY2023 · CA · contact PI
Cyclin C-CDK8/19 kinases in development and in cancer$525,969
R01 · FY2022 · CA · contact PI
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment$468,091
R01 · FY2022 · CA · contact PI
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment$456,860
R01 · FY2022 · CA · contact PI
The Function of CDK5 in Metastasis$432,500
R01 · FY2022 · CA · contact PI
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition$349,318
P50 · FY2022 · CA · contact PI
Targeting CDK4 and CDK6 kinases in breast cancer development$344,841
P01 · FY2022 · CA · contact PI
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment$477,643
R01 · FY2021 · CA · contact PI
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment$466,183
R01 · FY2021 · CA · contact PI
The Function of CDK5 in Metastasis$441,325
R01 · FY2021 · CA · contact PI
Targeting CDK4 and CDK6 kinases in breast cancer development$351,879
P01 · FY2021 · CA · contact PI
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition$281,140
P50 · FY2021 · CA · contact PI
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment$477,643
R01 · FY2020 · CA · contact PI
CDC7 kinase in normal and cancer cells: potential implications for cancer treatment$466,183
R01 · FY2020 · CA · contact PI
The Function of CDK5 in Metastasis$441,325
R01 · FY2020 · CA · contact PI
Novel functions of D-type and E-type cyclins in normal and in cancer cells$431,042
R01 · FY2020 · CA · contact PI
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition$390,525
P50 · FY2020 · CA · contact PI
Targeting CDK4 and CDK6 kinases in breast cancer development$351,879
P01 · FY2020 · CA · contact PI
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment$477,643
R01 · FY2019 · CA · contact PI
The Function of CDK5 in Metastasis$441,325
R01 · FY2019 · CA · contact PI
The function of cyclin C in tumorigenesis$439,962
R01 · FY2019 · CA · contact PI
Novel functions of D-type and E-type cyclins in normal and in cancer cells$418,111
R01 · FY2019 · CA · contact PI
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition$275,841
P50 · FY2019 · CA · contact PI
The function of cyclin C in tumorigenesis$453,569
R01 · FY2018 · CA · contact PI
Novel functions of D-type and E-type cyclins in normal and in cancer cells$431,042
R01 · FY2018 · CA · contact PI
Targeting Cell Cycle Machinery in Breast Cancer$282,270
P01 · FY2018 · CA · contact PI
The function of cyclin C in tumorigenesis$453,569
R01 · FY2017 · CA · contact PI
Cyclin A Function in Stem Cells and in Neoplasia$451,215
R01 · FY2017 · CA · contact PI
Novel functions of D-type and E-type cyclins in normal and in cancer cells$431,042
R01 · FY2017 · CA · contact PI
Targeting Cell Cycle Machinery in Breast Cancer$279,864
P01 · FY2017 · CA · contact PI
2017 Cell Growth and Proliferation Gordon Research Conference & Gordon Research Seminar$4,000
R13 · FY2017 · CA · contact PI
The function of cyclin C in tumorigenesis$453,569
R01 · FY2016 · CA · contact PI
Cyclin A Function in Stem Cells and in Neoplasia$451,215
R01 · FY2016 · CA · contact PI
Novel functions of D-type and E-type cyclins in normal and in cancer cells$431,042
R01 · FY2016 · CA · contact PI
Cyclin-Dependent Kinases in Oncogenesis$343,418
R01 · FY2016 · CA · contact PI
Targeting Cell Cycle Machinery in Breast Cancer$285,976
P01 · FY2016 · CA · contact PI
The function of cyclin C in tumorigenesis$453,569
R01 · FY2015 · CA · contact PI
Cyclin A Function in Stem Cells and in Neoplasia$451,215
R01 · FY2015 · CA · contact PI
Cyclin-Dependent Kinases in Oncogenesis$343,686
R01 · FY2015 · CA · contact PI
Targeting Cell Cycle Machinery in Breast Cancer$292,783
P01 · FY2015 · CA · contact PI
Cyclin A Function in Stem Cells and in Neoplasia$437,679
R01 · FY2014 · CA · contact PI
Cyclin-Dependent Kinases in Oncogenesis$333,627
R01 · FY2014 · CA · contact PI
Targeting Cell Cycle Machinery in Breast Cancer$307,798
P01 · FY2014 · CA · contact PI
The Molecular Function of D-cyclins in T-ALL$224,001
P01 · FY2014 · CA · contact PI
Cyclin A Function in Stem Cells and in Neoplasia$451,215
R01 · FY2013 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$417,290
R01 · FY2013 · CA · contact PI
E-Cyclins in normal and oncogenic proliferation$375,276
R01 · FY2013 · CA · contact PI
Cyclin-Dependent Kinases in Oncogenesis$323,546
R01 · FY2013 · CA · contact PI
Molecular Function of Cyclin D1 in Breast Development and Breast Cancer$286,630
P01 · FY2013 · CA · contact PI
The Molecular Function of D-cyclins in T-ALL$192,084
P01 · FY2013 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$445,988
R01 · FY2012 · CA · contact PI
Cyclin A Function in Normal Proliferation and in Neoplasia$434,038
R01 · FY2012 · CA · contact PI
E-Cyclins in normal and oncogenic proliferation$400,343
R01 · FY2012 · CA · contact PI
Cyclin-Dependent Kinases in Oncogenesis$344,443
R01 · FY2012 · CA · contact PI
Molecular Function of Cyclin D1 in Breast Development and Breast Cancer$306,512
P01 · FY2012 · CA · contact PI
The Molecular Function of D-cyclins in T-ALL$204,961
P01 · FY2012 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$448,113
R01 · FY2011 · CA · contact PI
Cyclin A Function in Normal Proliferation and in Neoplasia$435,992
R01 · FY2011 · CA · contact PI
E-Cyclins in normal and oncogenic proliferation$401,491
R01 · FY2011 · CA · contact PI
Molecular Function of Cyclin D1 in Breast Development and Breast Cancer$308,248
P01 · FY2011 · CA · contact PI
The Molecular Function of D-cyclins in T-ALL$205,596
P01 · FY2011 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$461,278
R01 · FY2010 · CA · contact PI
Cyclin A Function in Normal Proliferation and in Neoplasia$451,557
R01 · FY2010 · CA · contact PI
E-Cyclins in normal and oncogenic proliferation$413,987
R01 · FY2010 · CA · contact PI
Molecular Function of Cyclin D1 in Breast Development and Breast Cancer$319,992
P01 · FY2010 · CA · contact PI
The Molecular Function of D-cyclins in T-ALL$212,281
P01 · FY2010 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$449,514
R01 · FY2009 · CA · contact PI
Cyclin A Function in Normal Proliferation and in Neoplasia$444,799
R01 · FY2009 · CA · contact PI
E-Cyclins in normal and oncogenic proliferation$401,482
R01 · FY2009 · CA · contact PI
Molecular Function of Cyclin D1 in Breast Development and Breast Cancer$321,325
P01 · FY2009 · CA · contact PI
Cell cycle machinery in breast oncogenesis$299,640
R01 · FY2009 · CA · contact PI
Cyclins and Cyclin-dependent kinases as targets for protection against radiation$266,836
U19 · FY2009 · AI · contact PI
Cyclin A Function in Normal Proliferation and in Neoplasia$432,170
R01 · FY2008 · CA · contact PI
E-cyclins in normal and oncogenic proliferation$344,762
R01 · FY2008 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$340,435
R01 · FY2008 · CA · contact PI
Cell cycle machinery in breast oncogenesis$299,640
R01 · FY2008 · CA · contact PI
Cell Cycle Abnormalities in Thymic Malignancy$297,010
P01 · FY2008 · CA · contact PI
Cyclins and Cyclin-dependent kinases as targets for protection against radiation$266,836
U19 · FY2008 · AI · contact PI
Oncogenic Signaling in Human Mammary Epithelium$189,641
P01 · FY2008 · CA · contact PI
E-cyclins in normal and oncogenic proliferation$341,351
R01 · FY2007 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$337,111
R01 · FY2007 · CA · contact PI
Cyclins and Cyclin-dependent kinases as targets for protection against radiation$300,307
U19 · FY2007 · AI · contact PI
Cell cycle machinery in breast oncogenesis$299,640
R01 · FY2007 · CA · contact PI
Cell Cycle Abnormalities in Thymic Malignancy$294,251
P01 · FY2007 · CA · contact PI
Oncogenic Signaling in Human Mammary Epithelium$187,805
P01 · FY2007 · CA · contact PI
E-cyclins in normal and oncogenic proliferation$348,828
R01 · FY2006 · CA · contact PI
Analyses of the Molecular Functions for D-Cyclins$337,139
R01 · FY2006 · CA · contact PI
Cell cycle machinery in breast oncogenesis$308,232
R01 · FY2006 · CA · contact PI
Cyclins and Cyclin-dependent kinases as targets for protection against radiation-$268,833
U19 · FY2006 · AI · contact PI
Cell Cycle Abnormalities in Thymic Malignancy$218,572
P01 · FY2006 · CA · contact PI
Oncogenic Signaling in Human Mammary Epithelium$175,090
P01 · FY2006 · CA · contact PI
E-cyclins in normal and oncogenic proliferation$351,065
R01 · FY2005 · CA
Analyses of the Molecular Functions for D-Cyclins$335,257
R01 · FY2005 · CA
Cell cycle machinery in breast oncogenesis$314,557
R01 · FY2005 · CA
Cyclins and Cyclin-dependent kinases as targets for protection against radiation-$268,132
U19 · FY2005 · AI
Cell Cycle Abnormalities in Thymic Malignancy$212,206
P01 · FY2005 · CA
Oncogenic Signaling in Human Mammary Epithelium$169,993
P01 · FY2005 · CA
E-cyclins in normal and oncogenic proliferation$336,719
R01 · FY2004 · CA
Analyses of the Molecular Functions for D-Cyclins$323,451
R01 · FY2004 · CA
SPECIFIC ROLES FOR D-CYCLINS IN ONCOGENESIS$296,128
R01 · FY2004 · CA
ROLE OF CYCLINS D2 AND D3 IN LYPHIOD CELL PROLIFERATION$270,456
R01 · FY2004 · CA
Cell Cycle Abnormalities in Thymic Malignancy$206,026
P01 · FY2004 · CA
Oncogenic Signaling in Human Mammary Epithelium$165,040
P01 · FY2004 · CA
SPECIFIC ROLES FOR D-CYCLINS IN ONCOGENESIS$305,866
R01 · FY2003 · CA
ROLE OF CYCLINS D2 AND D3 IN LYPHIOD CELL PROLIFERATION$269,772
R01 · FY2003 · CA
SPECIFIC ROLES FOR D-CYCLINS IN ONCOGENESIS$309,127
R01 · FY2002 · CA
ROLE OF CYCLINS D2 AND D3 IN LYPHIOD CELL PROLIFERATION$247,170
R01 · FY2002 · CA
SPECIFIC ROLES FOR D-CYCLINS IN ONCOGENESIS$270,998
R01 · FY2001 · CA
ROLE OF CYCLINS D2 AND D3 IN LYPHIOD CELL PROLIFERATION$247,800
R01 · FY2001 · CA
SPECIFIC ROLES FOR D-CYCLINS IN ONCOGENESIS$253,397
R01 · FY2000 · CA
ROLE OF CYCLINS D2 AND D3 IN LYPHIOD CELL PROLIFERATION$248,220
R01 · FY2000 · CA